AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CSL LIMITED

172.310

+0.7400.43%

Volume:1.50M

Turnover:259.17M

Market Cap:82.52B

PE:-23.02

High:175.365

Open:172.800

Low:171.000

Close:171.570

52wk High:219.589

52wk Low:90.000

Shares:478.91M

Float Shares:478.91M

Volume Ratio:1.27

T/O Rate:0.31%

Dividend:4.09

Dividend Rate:2.37%

EPS(TTM):-7.485

EPS(LYR):-7.485

ROE:-15.83%

ROA:7.26%

PB:3.99

PE(LYR):-23.02

Loading ...

Overview Company News Filings

Australia's Tga - Benpen Injection Products to Be Discontinued Progressively Starting With 600Mg Strength From 30 Nov Due to Commercial Reasons

THOMSON REUTERS

Australia's Tga - Supply of These Benzylpenicillin Sodium Injection Products Will Continue Until Stock Is Exhausted

THOMSON REUTERS

Australia's Therapeutic Goods Administration - Seqirus Notified to Discontinue All Strengths of Benpen Injection Products Progressively

THOMSON REUTERS

Australia's Tga - Alternative Australian-Registered Benzylpenicillin Sodium Injection Brands Expected to Be Available in Future

THOMSON REUTERS

Is Carlisle Companies (CSL) Offering Value After Recent Share Price Pullback?

Simply Wall St.

The Bull Case For CSL (ASX:CSL) Could Change Following Canadian HEMGENIX Reimbursement Milestone – Learn Why

Simply Wall St.

CSL Canada administers first HEMGENIX gene therapy dose to Canadian patient

CSL Canada Announces First Canadian Patient Receives Hemgenix® (Etranacogene Dezaparvovec) Hemophilia B Gene Therapy in Ontario, Canada

THOMSON REUTERS

3 ASX Dividend Stocks Yielding Up To 4.2%

Simply Wall St.

A Look At Carlisle Companies (CSL) Valuation After Recent Share Price Weakness

Simply Wall St.

Trade Desk, HubSpot, Dell, CSL, Oklo Trending With Analysts

Assessing CSL (ASX:CSL) Valuation After Interim CEO Review And Financial Update

Simply Wall St.

BUZZ-Australia's CSL on track for worst week in 8 months on forecast cut, impairments

BUZZ-Citi turns neutral on Australia's CSL on growth uncertainty, execution risks

CSL Enters Agreement to Boost Influenza Pandemic Preparedness in Latin America, Caribbean

MT Newswires Live

Australia R&D Changes Look Positive for CSL, Others -- Market Talk

CSL Seqirus signs long-term PAHO pandemic influenza vaccine supply agreement

BRIEF-PAHO Signs Agreement To Reserve Pandemic Influenza Vaccine Supply For LatAm & Caribbean

Paho Signs Agreement to Reserve Pandemic Influenza Vaccine Supply for Latin America and the Caribbean

THOMSON REUTERS

Australian shares fall for third day as banks weigh ahead of federal budget

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/CSL.AU/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CSL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","market":"AU","secType":"STK","nameCN":"CSL LIMITED","latestPrice":172.31,"timestamp":1788243120000,"preClose":171.57,"halted":0,"volume":1501636,"delay":0,"changeRate":0.004313108352276092,"nameEN":"CSL LIMITED","floatShares":478911979,"shares":478911979,"eps":-7.485134662469394,"marketStatus":"Not Yet Opened","change":0.74,"latestTime":"09-01 16:12:00 AEST","open":172.8,"high":175.365,"low":171,"amount":259171238,"amplitude":0.025442,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-7.485134662469394,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1788307200000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":171.57,"dividendRate":0.023648,"openAndCloseTimeList":[[1788220800000,1788242400000]],"volumeRatio":1.2656476434947121,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"CSL.AU","preClose":172.31,"auctionPrice":171.5,"auctionVolume":7429,"auctionTime":1788304277939,"referenceTime":1788258603092,"auction":1,"marketStatus":"盘前竞价","timestamp":1788304277939}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","floatShares":478911979,"roa":"7.26%","roe":"-15.83%","lyrEps":-7.485135,"volumeRatio":1.2656476434947121,"shares":478911979,"dividePrice":4.085345,"high":175.365,"amplitude":0.025442,"preClose":171.57,"low":171,"week52Low":90,"pbRate":"3.99","psRate":"3.73","week52High":219.589,"institutionHeld":0,"latestPrice":172.31,"eps":-7.485134662469394,"divideRate":0.023709,"volume":1501636,"delay":0,"ttmEps":-7.485134662469394,"open":172.8,"prevYearClose":170.408,"prevWeekClose":172.32,"prevMonthClose":171.57,"prevQuarterClose":114.74,"fiveDayClose":173.64,"twentyDayClose":128.83,"sixtyDayClose":99.47,"dividendPayoutRate":0.4488044711953849,"dividendGrowthYears":5,"dividendGrowthRate":0.003543182641490467,"fiveYearAvgDividendRate":0.018567360626050477},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CSL.AU\",params:#limit:5,,,undefined,":[{"date":"2026-09-09","symbol":"CSL.AU","amount":1.62,"announcedDate":"2026-08-18","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-09-10","defaultRemindTime":1788912000000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-10-02","payableDate":"2026-09-10","currency":"USD","dateTimestamp":1788876000000,"payDate":"2026-10-02"},{"date":"2026-08-18","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787011200000,"name":null,"time":"","dateTimestamp":1786975200000,"actualEps":null},{"date":"2026-03-10","symbol":"CSL.AU","amount":1.3,"announcedDate":"2026-02-11","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-03-11","name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-09","payableDate":"2026-03-11","currency":"USD","dateTimestamp":1773061200000,"payDate":"2026-04-09"},{"date":"2026-02-11","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770764400000,"name":null,"time":"","dateTimestamp":1770728400000,"actualEps":null},{"date":"2025-09-09","symbol":"CSL.AU","amount":1.62,"announcedDate":"2025-08-19","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-09-10","defaultRemindTime":1757376000000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-03","payableDate":"2025-09-10","currency":"USD","dateTimestamp":1757340000000,"payDate":"2025-10-03"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CSL.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-10","recordDate":"2020-09-11","paymentDate":"2020-10-09","value":1.469578,"currency":"AUD"},{"executeDate":"2021-03-04","recordDate":"2021-03-05","paymentDate":"2021-04-01","value":1.04,"currency":"USD"},{"executeDate":"2021-09-02","recordDate":"2021-09-03","paymentDate":"2021-09-30","value":1.062,"currency":"USD"},{"executeDate":"2022-03-07","recordDate":"2022-03-08","paymentDate":"2022-04-06","value":1.04,"currency":"USD"},{"executeDate":"2022-09-06","recordDate":"2022-09-07","paymentDate":"2022-10-05","value":1.062,"currency":"USD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CSL.AU\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2638744515","title":"Australia's Tga - Benpen Injection Products to Be Discontinued Progressively Starting With 600Mg Strength From 30 Nov Due to Commercial Reasons","url":"https://stock-news.laohu8.com/highlight/detail?id=2638744515","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638744515?lang=en_us&edition=fundamental","pubTime":"2026-05-27 15:03","pubTimestamp":1779865429,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nFWN4230Z1:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7511","CSL.AU","BK7501","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638574414","title":"Australia's Tga - Supply of These Benzylpenicillin Sodium Injection Products Will Continue Until Stock Is Exhausted","url":"https://stock-news.laohu8.com/highlight/detail?id=2638574414","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638574414?lang=en_us&edition=fundamental","pubTime":"2026-05-27 15:03","pubTimestamp":1779865429,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nFWN4230Z1:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7511","CSL.AU","BK7508","BK7067","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638574179","title":"Australia's Therapeutic Goods Administration - Seqirus Notified to Discontinue All Strengths of Benpen Injection Products Progressively","url":"https://stock-news.laohu8.com/highlight/detail?id=2638574179","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638574179?lang=en_us&edition=fundamental","pubTime":"2026-05-27 15:03","pubTimestamp":1779865429,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nFWN4230Z1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7511","BK7508","BK7501","BK7067","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638157441","title":"Australia's Tga - Alternative Australian-Registered Benzylpenicillin Sodium Injection Brands Expected to Be Available in Future","url":"https://stock-news.laohu8.com/highlight/detail?id=2638157441","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638157441?lang=en_us&edition=fundamental","pubTime":"2026-05-27 15:03","pubTimestamp":1779865429,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nFWN4230Z1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7511","CSL.AU","BK7067","BK7508","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637371921","title":"Is Carlisle Companies (CSL) Offering Value After Recent Share Price Pullback?","url":"https://stock-news.laohu8.com/highlight/detail?id=2637371921","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637371921?lang=en_us&edition=fundamental","pubTime":"2026-05-24 05:37","pubTimestamp":1779572265,"startTime":"0","endTime":"0","summary":"For investors considering whether Carlisle Companies stock at around US$333.80 offers value or appears fully priced, this article reviews what the numbers indicate about the current share price.\nThe stock is up 0.9% over the last week, down 5.6% over the past month, up 1.6% year to date, and the 1-year return is a decline of 12.6%. The 3-year and 5-year returns stand at 59.1% and 83.2% respectively.\nRecent coverage has focused on Carlisle Companies as a US industrial conglomerate with...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/3061000-choice1-main-header/1585186603448","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3061000-choice1-main-header/1585186603448"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/capital-goods/nyse-csl/carlisle-companies/news/is-carlisle-companies-csl-offering-value-after-recent-share","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/capital-goods/nyse-csl/carlisle-companies/news/is-carlisle-companies-csl-offering-value-after-recent-share","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7511","BK7501","BK4086","BK7508","BK7067","CSL","LU0728928796.USD","LU1169590202.USD","SGXZ23171101.USD","CSL.AU","SG9999004303.SGD","DCF","LU1169589451.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636828748","title":"The Bull Case For CSL (ASX:CSL) Could Change Following Canadian HEMGENIX Reimbursement Milestone – Learn Why","url":"https://stock-news.laohu8.com/highlight/detail?id=2636828748","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636828748?lang=en_us&edition=fundamental","pubTime":"2026-05-20 21:45","pubTimestamp":1779284704,"startTime":"0","endTime":"0","summary":"CSL recently reported that its first Canadian patient has received HEMGENIX® for hemophilia B at London Health Sciences Centre, following public reimbursement agreements that now provide access in Ontario and British Columbia while other provinces review coverage.\nThis early real-world use of HEMGENIX® under public funding in Canada highlights how CSL’s high-value gene therapy portfolio is beginning to translate into tangible patient access and market uptake.\nNext, we’ll examine how this...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/the-bull-case-for-csl-asxcsl-could-change-following-canadian","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/the-bull-case-for-csl-asxcsl-could-change-following-canadian","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7067","AIYY","BK7501","AIPO","BK7508","LU1169589451.USD","CSL","LU0728928796.USD","CHAT","ARTY","BK4585","BK7511","AI","BK4543","BK4086","BK4587","BK4588","LU1169590202.USD","BK4551","BK4023","BK4528","SGXZ23171101.USD","AGIX","SG9999004303.SGD","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636845972","title":"CSL Canada administers first HEMGENIX gene therapy dose to Canadian patient","url":"https://stock-news.laohu8.com/highlight/detail?id=2636845972","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636845972?lang=en_us&edition=fundamental","pubTime":"2026-05-20 18:26","pubTimestamp":1779272807,"startTime":"0","endTime":"0","summary":"CSL’s unit CSL Canada administered HEMGENIX, its one-time hemophilia B gene therapy, to the first Canadian patient outside a clinical trial at London Health Sciences Centre in Ontario.Public reimbursement is now in place in Ontario and British Columbia following a pan-Canadian Pharmaceutical Alliance agreement, using the provinces’ exceptional access pathways.The treatment is indicated in Canada for adults with hemophilia B who require routine prophylaxis, with no clinical experience cited for mild or moderate disease with Factor IX activity above 2%.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CSL Limited published the original content used to generate this news brief on May 20, 2026, and is solely responsible for the information c","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nNDL7HzQ9r:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","BK7067","BK7501","BK7508","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636848079","title":"CSL Canada Announces First Canadian Patient Receives Hemgenix® (Etranacogene Dezaparvovec) Hemophilia B Gene Therapy in Ontario, Canada","url":"https://stock-news.laohu8.com/highlight/detail?id=2636848079","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636848079?lang=en_us&edition=fundamental","pubTime":"2026-05-20 18:00","pubTimestamp":1779271208,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nTUA7VKBHG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CSL.AU","BK7067","BK7511","BK7508","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636400461","title":"3 ASX Dividend Stocks Yielding Up To 4.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636400461","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636400461?lang=en_us&edition=fundamental","pubTime":"2026-05-19 03:09","pubTimestamp":1779131360,"startTime":"0","endTime":"0","summary":"As the Australian market grapples with global uncertainties and fluctuating commodity prices, investors are increasingly seeking stability amidst the volatility. In such an environment, dividend stocks can offer a reliable income stream, making them an attractive option for those looking to balance their portfolios while navigating current market conditions.","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/3-asx-dividend-stocks-yielding-up-to-42","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/3-asx-dividend-stocks-yielding-up-to-42","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["EQT.AU","GIVE.AU","ZYAU.AU","SDF.AU","BK7511","XJO.AU","BK7101","OZR.AU","XKO.AU","VAP.AU","BK7067","E200.AU","VAS.AU","BK7501","QRE.AU","BK4585","BK4588","NST.AU","EIGA.AU","VIG","BEAR.AU","PPC.AU","JIN.AU","IISV.AU","GEAR.AU","IMLC.AU","SLF.AU","BK7141","IIGF.AU","XAO.AU","BK7104","BK7506","OZF.AU","KSL.AU","CSL.AU","DACE.AU","QFN.AU","AUB.AU","FID.AU","SGLLV.AU","BK7508","STW.AU","CBA.AU","BBOZ.AU","BK7078","BK7135","MFF.AU","IOZ.AU","BK7062","BK7145"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636706068","title":"A Look At Carlisle Companies (CSL) Valuation After Recent Share Price Weakness","url":"https://stock-news.laohu8.com/highlight/detail?id=2636706068","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636706068?lang=en_us&edition=fundamental","pubTime":"2026-05-17 07:31","pubTimestamp":1778974308,"startTime":"0","endTime":"0","summary":"Recent share performance and business snapshot\nCarlisle Companies (CSL) has drawn investor attention after a period of mixed share performance, with the stock down over the past month and past 3 months but ahead over the past 3 years and 5 years.\nThe company focuses on building envelope products across its Carlisle Construction Materials and Carlisle Weatherproofing Technologies segments. It generated US$4,976.2m in revenue and US$728.6m in net income, with operations concentrated in the...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/3061000-choice1-main-header/1585186603448","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3061000-choice1-main-header/1585186603448"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/capital-goods/nyse-csl/carlisle-companies/news/a-look-at-carlisle-companies-csl-valuation-after-recent-shar-2","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/capital-goods/nyse-csl/carlisle-companies/news/a-look-at-carlisle-companies-csl-valuation-after-recent-shar-2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7508","SG9999004303.SGD","BK7501","SGXZ23171101.USD","BK7067","LU1169590202.USD","LU0728928796.USD","BK7511","CSL","CSL.AU","LU1169589451.USD","BK4086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635050090","title":"Trade Desk, HubSpot, Dell, CSL, Oklo Trending With Analysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2635050090","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635050090?lang=en_us&edition=fundamental","pubTime":"2026-05-16 17:00","pubTimestamp":1778922029,"startTime":"0","endTime":"0","summary":"Analysts are intrested in these 5 stocks: ( ($TTD) ), ( ($HUBS) ), ( ($DELL) ), ( ($CMXHF) ) and ( ($OKLO) ). Here is a breakdown of their recent","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/trade-desk-hubspot-dell-csl-oklo-trending-with-analysts?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/trade-desk-hubspot-dell-csl-oklo-trending-with-analysts?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4535","LU1267930227.SGD","TTD","BK4086","LU1169590202.USD","BK4543","DELL","LU0496365809.HKD","LU2065170008.USD","BK4528","LU2054465674.USD","CSL.AU","BK4023","LU2065171402.SGD","LU2210150020.SGD","LU0976567544.SGD","LU2065171311.SGD","BK4170","BK4588","TTDU","IE00BMPRXN33.USD","BK4585","LU0267386448.USD","SG9999004303.SGD","LU1548497426.USD","BK4613","LU2210149790.SGD","IE00BMPRXR70.SGD","LU1046421795.USD","LU0128525689.USD","IE00B19Z9Z06.USD","LU0211326839.USD","LU1169589451.USD","BK4515","LU2065169927.USD","OKLO","IE00B19Z9P08.USD","IE00BZ9MQY76.HKD","BK4548","LU0211326755.USD","BK4009","LU0348723411.USD","LU1235294995.USD","LU1823568750.SGD","HUBS","LU1720051108.HKD","DLLL","LU2095319765.USD","LU0052756011.USD","LU0310800965.SGD","SGXZ23171101.USD","LU1720051017.SGD","LU2357305700.SGD","LU0728928796.USD","IE00B894F039.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635705295","title":"Assessing CSL (ASX:CSL) Valuation After Interim CEO Review And Financial Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2635705295","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635705295?lang=en_us&edition=fundamental","pubTime":"2026-05-16 11:54","pubTimestamp":1778903640,"startTime":"0","endTime":"0","summary":"Interim CEO review and financial update draw investor focus\nCSL (ASX:CSL) has attracted fresh attention after a recent shareholder and analyst call covering the Interim CEO’s review of the past 3 months and a financial update, prompting investors to reassess the stock’s current setup.\nSee our latest analysis for CSL.\nCSL’s share price has fallen 43.03% year to date and the 1 year total shareholder return is down 58.49%. The recent call therefore comes after a sustained loss of momentum, with...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/assessing-csl-asxcsl-valuation-after-interim-ceo-review-and","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/assessing-csl-asxcsl-valuation-after-interim-ceo-review-and","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0728928796.USD","DCF","CSL","LU1169589451.USD","BK7501","BK7067","BK7508","BK7511","CSL.AU","SGXZ23171101.USD","BK4086","LU1169590202.USD","SG9999004303.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635936773","title":"BUZZ-Australia's CSL on track for worst week in 8 months on forecast cut, impairments","url":"https://stock-news.laohu8.com/highlight/detail?id=2635936773","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635936773?lang=en_us&edition=fundamental","pubTime":"2026-05-15 09:41","pubTimestamp":1778809296,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's CSL on track for worst week in 8 months on forecast cut, impairments** Shares of CSL CSL.AX up 0.8% at A$98.08 ** Stock on track for a weekly drop of 18.2%, its biggest drop since mid-August** Biotech major on Monday trimmed it fiscal 2026 earnings and revenue forecasts; flags $5 billion of non-cash impairments over FY26-27** Attributes forecast downgrade to delays in payoff from growth initiatives and revenue headwinds from U.S. immunoglobulin inventory normalisation** Shares fell nearly 16% on Monday** CSL down 43.2% YTD, including the day's moves  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nL4N41S05N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7508","BK7067","CSL.AU","BK7511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635612761","title":"BUZZ-Citi turns neutral on Australia's CSL on growth uncertainty, execution risks","url":"https://stock-news.laohu8.com/highlight/detail?id=2635612761","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635612761?lang=en_us&edition=fundamental","pubTime":"2026-05-14 12:03","pubTimestamp":1778731420,"startTime":"0","endTime":"0","summary":"BUZZ-Citi turns neutral on Australia's CSL on growth uncertainty, execution risks ** Shares of Australian biotech firm CSL Ltd CSL.AX fall more than 2% to A$96.72** Citi downgrades stock to \"neutral\" after FY26 guidance cut and leadership review, citing rising investor scepticism over growth outlook** Says shares have fallen about 18% since the announcement on Monday, now trading near 11x Citi's FY27 core EPS estimates** Says investors are questioning recovery prospects for China albumin and CSL's ability to deliver more than low-to mid-single-digit NPATA growth in FY27** Notes uncertainty around leadership transition, with new CEO search seen as delaying execution of strategic changes** 7 of 16 analysts rate the stock \"buy\" or higher, and 9 \"hold\"; their median PT is A$150 – LSEG data** Stock down 43.94% this year, including the day's move  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nL4N41R09T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7508","BK7511","BK7501","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635222734","title":"CSL Enters Agreement to Boost Influenza Pandemic Preparedness in Latin America, Caribbean","url":"https://stock-news.laohu8.com/highlight/detail?id=2635222734","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635222734?lang=en_us&edition=fundamental","pubTime":"2026-05-13 09:23","pubTimestamp":1778635423,"startTime":"0","endTime":"0","summary":"CSL  signed a multi-year agreement with the Pan American Health Organization to boost preparedness for potential influenza pandemics in Latin America and the Caribbean, according to a Wednesday statement.Under the deal, CSL Seqirus has reserved \"millions\" of vaccine doses that participating countries across the region can order if an influenza pandemic is declared, the company said.CSL Seqirus will collaborate with Argentine production partner Sinergium Biotech to ensure rapid manufacturing and delivery of the vaccines if required.CSL shares advanced 1% in recent Wednesday trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0728928796.USD","BK7508","BK7511","BK7067","LU1169589451.USD","CSL","SGXZ23171101.USD","BK4086","CSL.AU","BK7501","SG9999004303.SGD","LU1169590202.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635229966","title":"Australia R&D Changes Look Positive for CSL, Others -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2635229966","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635229966?lang=en_us&edition=fundamental","pubTime":"2026-05-13 07:27","pubTimestamp":1778628420,"startTime":"0","endTime":"0","summary":"Australian government changes to R&D taxation look positive for locally listed medical manufacturers, RBC Capital Markets analyst Craig Wong-Pan says. The government is increasing the amount of R&D expenditure that companies can claim as a tax offset, while also lifting R&D disbursements paid out from the sovereign Medical Research Future Fund. Wong-Pan thinks this looks like good news for pharmaceutical manufacturer CSL, breath-tech maker ResMed, hearing-implant developer Cochlear and infection-prevention company Nanosonics. From July 2028, the tax offset for experimental core R&D will rise to 50%. ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","NAN.AU","RMD","BK4548","SGXZ23171101.USD","BK7007","LU1169589451.USD","BK4588","BK4504","BK7067","BK7501","LU0728928796.USD","IE00B5TLWC47.USD","SG9999004303.SGD","BK7508","CSL.AU","BK7503","LU0170899867.USD","CSL","LU2008162690.USD","COH.AU","LU1169590202.USD","RMD.AU","BK7511","LU2177674079.SGD","BK4086","BK7126","BK4082","BK4567"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635244759","title":"CSL Seqirus signs long-term PAHO pandemic influenza vaccine supply agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2635244759","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635244759?lang=en_us&edition=fundamental","pubTime":"2026-05-13 03:08","pubTimestamp":1778612929,"startTime":"0","endTime":"0","summary":"CSL Seqirus, unit of CSL Limited, signed multi-year pandemic influenza preparedness agreement with PAHO Regional Revolving Fund covering Latin America and Caribbean.Deal reserves millions of doses of pandemic influenza vaccine for participating countries, with Seqirus required to rapidly manufacture and deliver doses once WHO declares influenza pandemic.Seqirus to use global influenza manufacturing network, with Sinergium Biotech supporting regional fill-finish and distribution from Argentina.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CSL Limited published the original content used to generate this news brief on May 12, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDLbtmrWS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7067","CSL.AU","BK7511","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635244606","title":"BRIEF-PAHO Signs Agreement To Reserve Pandemic Influenza Vaccine Supply For LatAm & Caribbean","url":"https://stock-news.laohu8.com/highlight/detail?id=2635244606","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635244606?lang=en_us&edition=fundamental","pubTime":"2026-05-13 02:46","pubTimestamp":1778611563,"startTime":"0","endTime":"0","summary":"BRIEF-PAHO Signs Agreement To Reserve Pandemic Influenza Vaccine Supply For LatAm & CaribbeanMay 12  - PAHO:PAHO SIGNS AGREEMENT TO RESERVE PANDEMIC INFLUENZA VACCINE SUPPLY FOR LATIN AMERICA AND THE CARIBBEANPAHO: AGREEMENT WITH CSL SEQIRUS AIMED AT SECURING RESERVED SHARE OF PANDEMIC INFLUENZA VACCINES PRODUCTION FOR COUNTRIES IN LATIN AMERICA, CARIBBEAN","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nFWN41P1K1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7511","BK7501","CSL.AU","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635443462","title":"Paho Signs Agreement to Reserve Pandemic Influenza Vaccine Supply for Latin America and the Caribbean","url":"https://stock-news.laohu8.com/highlight/detail?id=2635443462","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635443462?lang=en_us&edition=fundamental","pubTime":"2026-05-13 02:30","pubTimestamp":1778610633,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nFWN41P1K1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","CSL.AU","BK7511","BK7501","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634298817","title":"Australian shares fall for third day as banks weigh ahead of federal budget","url":"https://stock-news.laohu8.com/highlight/detail?id=2634298817","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634298817?lang=en_us&edition=fundamental","pubTime":"2026-05-12 15:08","pubTimestamp":1778569706,"startTime":"0","endTime":"0","summary":"Australian shares fallfor third day as banks weigh ahead of federal budgetUpdates to closeCBA slips ahead of resultsHealthcare posts 6th straight loss as CSL rout extendsDroneShield tumbles 9.9% after regulatory probe disclosureBy Kumar Tanishk","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nL4N41P087:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0572940350.SGD","LU1309081286.SGD","IE00BWDBJ516.SGD","LU0898667661.SGD","LU0345780950.USD","LU1078025761.USD","LU2463526074.USD","LU0971552830.HKD","LU0266512473.USD","LU0654597011.USD","LU0345777147.USD","LU1302929846.USD","WBC.AU","LU0161305163.EUR","LU0345781412.USD","LU0456854461.SGD","IE00BQJZX424.USD","LU0171293334.USD","RIO.UK","BK7115","LU0955623706.USD","LU1064927863.SGD","LU1130305938.SGD","LU1487256676.USD","LU0330918003.SGD","LU0955669360.SGD","BK7511","LU0612318971.USD","NAB.AU","BK7135","CSL.AU","LU0505663152.USD","BK7095","LU0831103253.SGD","AN3PL.AU","LU0788109121.HKD","ANZ.AU","LU0955648018.USD","BHP.AU","LU0264606111.USD","LU0612318385.USD","DRO.AU","LU0971552673.USD","IE00B3M56506.USD","CBA.AU","LU0630314457.HKD","BK7067","BK7501","BK7507","SG9999002521.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}